Europa. New EMCDDA report shows grounds for hope in treating hepatitis C
Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus (HCV). Around 115 million people worldwide have been infected at some point in their life by HCV. Two-thirds of these are estimated to be chronically infected, over 5 million within the European Union. The infection is highly prevalent among people who inject drugs who can contract HCV through the sharing of needles, syringes and other injecting equipment. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks at new opportunities for the effective prevention and treatment of the disease, including the use of new generations of medicines. (EMCDDA, Lissabon, 28.07.2016)
http://www.emcdda.europa.eu/news/2016/8/hepatitis-c-among-drug-users-in-europe